Role of the Survivin gene in pathophysiology

American Journal of Pathology

Volumn 169, Issue 1, 2006, Pages 1-11

  Li, Fengzhi ^a,b,c   Brattain, Michael G ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b TONGJI UNIVERSITY   (China)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTERFERON; CASPASE INHIBITOR; COMPLEMENTARY DNA; CYCLOOXYGENASE 2 INHIBITOR; DNA VACCINE; INDOMETACIN; INTERLEUKIN 2; MESSENGER RNA; NONSTEROID ANTIINFLAMMATORY AGENT; OKT 3; SURVIVIN;

APOPTOSIS; BRAIN; BRAIN DISEASE; BREAST CANCER; CANCER; CANCER CELL; CANCER THERAPY; CELL CYCLE; CELL DIVISION; CELL PROLIFERATION; CELL SURVIVAL; EMBRYO DEVELOPMENT; ENDOMETRIUM; ENDOMETRIUM CANCER; GASTROINTESTINAL TRACT; HEMATOPOIETIC CELL; HUMAN; LIVER; LIVER REGENERATION; LYMPHOCYTE DIFFERENTIATION; MULTIPLE SCLEROSIS; NONHUMAN; OOCYTE; PANCREAS; PANCREAS CANCER; PATHOPHYSIOLOGY; PLACENTA; PRIORITY JOURNAL; REVIEW; SPERMATOGENESIS; STOMACH CANCER; T LYMPHOCYTE; TESTIS;

EID: 33745714787     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2006.060121     Document Type: Review

References (76)

1. Li F: Survivin study: what is the next wave? J Cell Physiol 2003, 197:8-29
2. Li F, Ling X: Survivin study: an update of "What is the next wave?" J Cell Physiol 2006, [E-pub ahead of print]
3. Altieri DC: Validating survivin as a cancer therapeutic target. Nat Rev Cancer 2003, 3:46-54
4. Mesri M, Wall NR, Li J, Kim RW, Altieri DC: Cancer gene therapy using a survivin mutant adenovirus. J Clin Invest 2001, 108:981-990
5. O'Connor DS, Wall NR, Porter AC, Altieri DC: A p34(cdc2) survival checkpoint in cancer. Cancer Cell 2002, 2:43-54
6. Wall NR, O'Connor DS, Plescia J, Pommier Y, Altieri DC: Suppression of survivin phosphorylation on Thr34 by flavopiridol enhances tumor cell apoptosis. Cancer Res 2003, 63:230-235
7. Plescia J, Salz W, Xia F, Pennati M, Zaffaroni N, Daidone MG, Meli M, Dohi T, Fortugno P, Nefedova Y, Gabrilovich DI, Colombo G, Altieri DC: Rational design of shepherdin, a novel anticancer agent. Cancer Cell 2005, 7:457-468
8. Xiang R, Mizutani N, Luo Y, Chiodoni C, Zhou H, Mizutani M, Ba Y, Becker JC, Reisfeld RA: A DNA vaccine targeting survivin combines apoptosis with suppression of angiogenesis in lung tumor eradication. Cancer Res 2005, 65:553-561
9. Otto K, Andersen MH, Eggert A, Keikavoussi P, Pedersen LO, Rath JC, Bock M, Brocker EB, Straten PT, Kampgen E, Becker JC: Lack of toxicity of therapy-induced T cell responses against the universal tumour antigen survivin. Vaccine 2005, 23:884-889
10. Dohi T, Beltrami E, Wall NR, Plescia J, Altieri DC: Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis. J Clin Invest 2004, 114:1117-1127
11. Wang Q, Greene MI: EGFR enhances survivin expression through the phosphoinositide 3 (PI-3) kinase signaling pathway. Exp Mol Pathol 2005, 79:100-107
12. Qiu L, Wang Q, Di W, Jiang Q, Schefeller E, Derby S, Wanebo H, Yan B, Wan Y: Transient activation of EGFR/AKT cell survival pathway and expression of survivin contribute to reduced sensitivity of human melanoma cells to betulinic acid. Int J Oncol 2005, 27:823-830
13. Adida C, Crotty PL, McGrath J, Berrebi D, Diebold J, Altieri DC: Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. Am J Pathol 1998, 152:43-49
14. Murphy CR, Sabel JL, Sandler AD, Dagle JM: Survivin mRNA is down-regulated during early Xenopus laevis embryogenesis. Dev Dyn 2002, 225:597-601
15. Uren AG, Wong L, Pakusch M, Fowler KJ, Burrows FJ, Vaux DL, Choo KH: Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype. Curr Biol 2000, 10:1319-1328
16. Conway EM, Pollefeyt S, Steiner-Mosonyi M, Luo W, Devriese A, Lupu F, Bono F, Leducq N, Dol F, Schaeffer P, Collen D, Herbert JM: Deficiency of survivin in transgenic mice exacerbates Fas-induced apoptosis via mitochondrial pathways. Gastroenterology 2002, 123:619-631
17. Kawamura K, Sato N, Fukuda J, Kodama H, Kumagai J, Tanikawa H, Shimizu Y, Tanaka T: Survivin acts as an antiapoptotic factor during the development of mouse preimplantation embryos. Dev Biol 2003, 256:331-341
18. Jiang Y, de Bruin A, Caldas H, Fangusaro J, Hayes J, Conway EM, Robinson ML, Altura RA: Essential role for survivin in early brain development. J Neurosci 2005, 25:6962-6970
19. Li F: Role of survivin and its splice variants in tumorigenesis. Br J Cancer 2005, 92:212-216
20. Formby B, Wiley TS: Bcl-2, survivin and variant CD44 v7-v10 are downregulated and p53 is upregulated in breast cancer cells by progesterone: inhibition of cell growth and induction of apoptosis. Mol Cell Biochem 1999, 202:53-61
21. Zhang M, Yang J, Li F: Transcriptional and posttranscriptional controls of survivin in cancer cells: essential interfaces for developing novel approaches for cancer treatment. J Exp Clin Cancer Res 2006, in press
22. Fukuda S, Pelus LM: Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34(+) cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesis. Blood 2001, 98:2091-2100
23. Fukuda S, Pelus LM: Elevation of survivin levels by hematopoietic growth factors occurs in quiescent CD34(+) hematopoietic stem and progenitor cells before cell cycle entry. Cell Cycle 2002, 1:322-326
24. Fukuda S, Foster RG, Porter SB, Pelus LM: The antiapoptosis protein survivin is associated with cell cycle entry of normal cord blood CD34(+) cells and modulates cell cycle and proliferation of mouse hematopoietic progenitor cells. Blood 2002, 100:2463-2471
25. Altznauer F, Martinelli S, Yousefi S, Thurig C, Schmid I, Conway EM, Schoni MH, Vogt P, Mueller C, Fey MF, Zangemeister-Wittke U, Simon HU: Inflammation-associated cell cycle-independent block of apoptosis by survivin in terminally differentiated neutrophils. J Exp Med 2004, 199:1343-1354
26. Gurbuxani S, Xu Y, Keerthivasan G, Wickrema A, Crispino JD: Differential requirements for survivin in hematopoietic cell development. Proc Natl Acad Sci USA 2005, 102:11480-11485
27. Li F, Ling X, Huang H, Brattain L, Apontes P, Wu J, Binderup L, Brattain MG: Differential regulation of survivin expression and apoptosis by vitamin D(3) compounds in two isogenic MCF-7 breast cancer cell sublines. Oncogene 2005, 24:1385-1395
28. Tripp A, Banerjee P, Sieburg M, Planelles V, Li F, Feuer G: Induction of cell cycle arrest by human T-cell lymphotropic virus type 1 Tax in hematopoietic progenitor (CD34+) cells: modulation of p21cip1/waf1 and p27kip1 expression. J Virol 2005, 79:14069-14078
29. Fukuda S, Mantel CR, Pelus LM: Survivin regulates hematopoietic progenitor cell proliferation through p21WAF1/Cip1-dependent and -independent pathways. Blood 2004, 103:120-127
30. Braun SE, Mantel C, Rosenthal M, Cooper S, Liu L, Robertson KA, Hromas R, Broxmeyer HE: A positive effect of p21cip1/waf1 in the colony formation from murine myeloid progenitor cells as assessed by retroviral-mediated gene transfer. Blood Cells Mol Dis 1998, 24:138-148
31. Kobayashi Y, Yukiue H, Sasaki H, Fukai I, Yokoyama T, Kiriyama M, Yamakawa Y, Maeda M, Fujii Y: Developmentally regulated expression of survivin in the human thymus. Hum Immunol 2002, 63:101-107
32. Xing Z, Conway EM, Kang C, Winoto A: Essential role of survivin, an inhibitor of apoptosis protein, in T cell development, maturation, and homeostasis. J Exp Med 2004, 199:69-80
33. Kornacker M, Verneris MR, Kornacker B, Scheffold C, Negrin RS: Survivin expression correlates with apoptosis resistance after lymphocyte activation and is found preferentially in memory T cells, Immunol Lett 2001, 76:169-173
34. Okada H, Bakal C, Shahinian A, Elia A, Wakeham A, Suh WK, Duncan GS, Ciofani M, Rottapel R, Zuniga-Pflucker JC, Mak TW: Survivin loss in thymocytes triggers p53-mediated growth arrest and p53-independent cell death. J Exp Med 2004, 199:399-410
35. Hikita S, Hatano M, Inoue A, Sekita N, Kobayashi K, Otaki M, Ogasawara T, Okada S, Hirasawa H, Tokuhisa T: Overexpression of TIAP/m-survivin in thymocytes enhances cell proliferation. Mol Immunol 2002, 39:289-298
36. Wang Z, Fukuda S, Pelus LM: Survivin regulates the p53 tumor suppressor gene family. Oncogene 2004, 23:8146-8153
37. Song J, So T, Cheng M, Tang X, Croft M: Sustained survivin expression from OX40 costimulatory signals drives T cell clonal expansion. Immunity 2005, 22:621-631
38. Sharief MK, Semra YK: Heightened expression of survivin in activated T lymphocytes from patients with multiple sclerosis. J Neuroimmunol 2001, 119:358-364
39. Sharief MK, Semra YK: Down-regulation of survivin expression in T lymphocytes after Interferon beta-1a treatment in patients with multiple sclerosis. Arch Neurol 2002, 59:1115-1121
40. Sharief MK, Noori MA, Douglas MR, Semra YK: Upregulated survivin expression in activated T lymphocytes correlates with disease activity in multiple sclerosis. Eur J Neurol 2002, 9:503-510
41. Ambrosini G, Adida C, Altieri DC: A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997, 3:917-921
42. Pennartz S, Belvindrah R, Tomiuk S, Zimmer C, Hofmann K, Conradt M, Bosio A, Cremer H: Purification of neuronal precursors from the adult mouse brain: comprehensive gene expression analysis provides new insights into the control of cell migration, differentiation, and homeostasis. Mol Cell Neurosci 2004, 25:692-706
43. Kobayashi K, Hatano M, Otaki M, Ogasawara T, Tokuhisa T: Expression of a murine homologue of the inhibitor of apoptosis protein is related to cell proliferation. Proc Natl Acad Sci USA 1999, 96:1457-1462
44. Altura RA, Olshefski RS, Jiang Y, Boue DR: Nuclear expression of survivin in paediatric ependymomas and choroid plexus tumours correlates with morphologic tumour grade. Br J Cancer 2003, 89:1743-1749
45. Li F, Yang J, Ramnath N, Javle MM, Tan D: Nuclear or cytoplasmic expression of survivin: what is the significance? Int J Cancer 2005, 114:509-512
46. Johnson EA, Svetlov SI, Pike BR, Tolentino PJ, Shaw G, Wang KK, Hayes RL, Pineda JA: Cell-specific upregulation of survivin after experimental traumatic brain injury in rats. J Neurotrauma 2004, 21:1183-1195
47. Johnson EA, Svetlov SI, Wang KK, Hayes RL, Pineda JA: Cell-specific DNA fragmentation may be attenuated by a survivin-dependent mechanism after traumatic brain injury in rats. Exp Brain Res 2005, 167:17-26
48. Conway EM, Zwerts F, Van Eygen V, DeVriese A, Nagai N, Luo W, Collen D: Survivin-dependent angiogenesis in ischemic brain: molecular mechanisms of hypoxia-induced up-regulation. Am J Pathol 2003, 163:935-946
49. Deguchi M, Shiraki K, Inoue H, Okano H, Ito T, Yamanaka T, Sugimoto K, Sakai T, Ohmori S, Murata K, Furusaka A, Hisatomi H, Nakano T: Expression of survivin during liver regeneration. Biochem Biophys Res Commun 2002, 297:59-64
50. Lu QP, Cao TJ, Zhang ZY, Liu W: Multiple gene differential expression patterns in human ischemic liver: safe limit of warm ischemic time. World J Gastroenterol 2004, 10:2130-2133
51. Wang K, Brems JJ, Gamelli RL, Ding J: Reversibility of caspase activation and its role during glycochenodeoxycholate-induced hepatocyte apoptosis. J Biol Chem 2005, 280:23490-23495
52. Liggins C, Orlicky DJ, Bloomquist LA, Gianani R: Developmentally regulated expression of survivin in human pancreatic islets. Pediatr Dev Pathol 2003, 6:392-397
53. Tashiro M, Nakamura H, Taguchi M, Yoshikawa H, Otsuki M: Expression of survivin after acute necrohemorrhagic pancreatitis in rats. Pancreas 2003, 26:160-165
54. Qiao JG, Zhang YQ, Yin YC, Tan Z: Expression of survivin in pancreatic cancer and its correlation to expression of Bcl-2. World J Gastroenterol 2004, 10:2759-2761
55. Chiou SK, Moon WS, Jones MK, Tarnawski AS: Survivin expression in the stomach: implications for mucosal integrity and protection. Biochem Biophys Res Commun 2003, 305:374-379
56. Chiou SK, Tanigawa T, Akahoshi T, Abdelkarim B, Jones MK, Tarnawski AS: Survivin: a novel target for indomethacin-induced gastric injury. Gastroenterology 2005, 128:63-73
57. Konturek PC, Konturek SJ, Bielanski W, Kania J, Zuchowicz M, Hartwich A, Rehfeld JF, Hahn EG: Influence of COX-2 inhibition by rofecoxib on serum and tumor progastrin and gastrin levels and expression of PPARgamma and apoptosis-related proteins in gastric cancer patients. Dig Dis Sci 2003, 48:2005-2017
58. Krysan K, Merchant FH, Zhu L, Dohadwala M, Luo J, Lin Y, Heuze-Vourc'h N, Pold M, Seligson D, Chia D, Goodglick L, Wang H, Strieter R, Sharma S, Dubinett S: COX-2-dependent stabilization of survivin in non-small cell lung cancer. FASEB J 2004, 18:206-208
59. Krysan K, Dalwadi H, Sharma S, Pold M, Dubinett S: Cyclooxygenase 2-dependent expression of survivin is critical for apoptosis resistance in non-small cell lung cancer. Cancer Res 2004, 64:6359-6362
60. Parashar B, Latha Shankar S, O'Guin K, Butler J, Vikram B, Shafit-Zagardo B: Inhibition of human neuroblastoma cell growth by CAY10404, a highly selective Cox-2 inhibitor. J Neurooncol 2005, 71:141-148
61. Tarnawski A, Pai R, Chiou SK, Chai J, Chu EC: Rebamipide inhibits gastric cancer growth by targeting survivin and Aurora-B. Biochem Biophys Res Commun 2005, 334:207-212
62. Zhang T, Otevrel T, Gao Z, Ehrlich SM, Fields JZ, Boman BM: Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res 2001, 61:8664-8667
63. Wang Y, Suominen JS, Hakovirta H, Parvinen M, Martinand-Mari C, Toppari J, Robbins I: Survivin expression in rat testis is upregulated by stem-cell factor. Mol Cell Endocrinol 2004, 218:165-174
64. Weikert S, Schrader M, Muller M, Krause H, Miller K: Expression of the apoptosis inhibitor survivin in testicular tissue of infertile patients. Int J Androl 2004, 27:161-165
65. Weikert S, Schrader M, Muller M, Schulze W, Krause H, Miller K: Expression levels of the inhibitor of apoptosis survivin in testes of patients with normal spermatogenesis and spermatogenic failure. Fertil Steril 2005, 83(Suppl 1):1100-1105
66. Weikert S, Christoph F, Schulze W, Krause H, Kempkensteffen C, Schostak M, Miller K, Schrader M: Testicular expression of survivin and human telomerase reverse transcriptase (hTERT) associated with spermatogenic function in infertile patients. Asian J Androl 2006, 8:95-100
67. Weikert S, Schrader M, Krause H, Schulze W, Muller M, Miller K: The inhibitor of apoptosis (IAP) survivin is expressed in human testicular germ cell tumors and normal testes. Cancer Lett 2005, 223:331-337
68. Endoh T, Tsuji N, Asanuma K, Yagihashi A, Watanabe N: Survivin enhances telomerase activity via up-regulation of specificity protein 1- and c-Myc-mediated human telomerase reverse transcriptase gene transcription. Exp Cell Res 2005, 305:300-311
69. Konno R, Yamakawa H, Utsunomiya H, Ito K, Sato S, Yajima A: Expression of survivin and Bcl-2 in the normal human endometrium. Mol Hum Reprod 2000, 6:529-534
70. Ueda M, Yamashita Y, Takehara M, Terai Y, Kumagai K, Ueki K, Kanda K, Yamaguchi H, Akise D, Hung YC, Ueki M: Survivin gene expression in endometriosis. J Clin Endocrinol Metab 2002, 87:3452-3459
71. Takai N, Miyazaki T, Nishida M, Nasu K, Miyakawa I: Survivin expression correlates with clinical stage, histological grade, invasive behavior and survival rate in endometrial carcinoma. Cancer Lett 2002, 184:105-116
72. Pallares J, Martinez-Guitarte JL, Dolcet X, Llobet D, Rue M, Palacios J, Prat J, Matias-Guiu X: Survivin expression in endometrial carcinoma: a tissue microarray study with correlation with PTEN and STAT-3. Int J Gynecol Pathol 2005, 24:247-253
73. Goteri G, Lucarini G, Pieramici T, Filosa A, Pugnaloni A, Montik N, Biagini G, Tranquilli AL, Fabris G, Ciavattini A, Lo Muzio L: Endothelial cell survivin is involved in the growth of ovarian endometriotic cysts. Anticancer Res 2005, 25:4313-4318
74. Shiozaki A, Kataoka K, Fujimura M, Yuki H, Sakai M, Saito S: Survivin inhibits apoptosis in cytotrophoblasts. Placenta 2003, 24:65-76
75. Lehner R, Bobak J, Kim NW, Shroyer AL, Shroyer KR: Localization of telomerase hTERT protein and survivin in placenta: relation to placental development and hydatidiform mole. Obstet Gynecol 2001, 97:965-970
76. Ka H, Hunt JS: Temporal and spatial patterns of expression of inhibitors of apoptosis in human placentas. Am J Pathol 2003, 163:413-422